M.Á. Climent
Impact in
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Surgery top 10%
- Bladder and Urothelial Cancer Treatments
- Urinary and Genital Oncology Studies
- Testicular diseases and treatments
Papers in
- Co-authors
- Dean F. Bajorin (4 shared papers)Ronald de Wit (4 shared papers)Andrea Necchi (4 shared papers)Daniel P. Petrylak (4 shared papers)Joaquim Bellmunt (5 shared papers)Yves Fradet (4 shared papers)K. Nam (1 shared paper)Stéphane Culine (1 shared paper)
- Journals
- Annals of Oncology (3 papers)Journal of Clinical Oncology (2 papers)World Neurosurgery (1 paper)European Journal of Cancer (1 paper)ESMO Open (1 paper)
- Partner nations
- SpainUnited StatesCanada
In The Last Decade
M.Á. Climent
11 papers receiving 393 citations
M.Á. Climent's Hit Papers
Peers
Comparison fields: 5 of 33
- Oncology 184
- Surgery 252
- Pulmonary and Respiratory Medicine 65
- Cancer Research 17
- Rheumatology 16
Countries citing papers authored by M.Á. Climent
This map shows the geographic impact of M.Á. Climent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.Á. Climent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.Á. Climent more than expected).
Fields of papers citing papers by M.Á. Climent
This network shows the impact of papers produced by M.Á. Climent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.Á. Climent. The network helps show where M.Á. Climent may publish in the future.
Co-authors
The 25 scholars most cited alongside M.Á. Climent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up Hit paper breakdown → | 2019 | 322 |
| 2 | 1993 | 34 | |
| 3 | 2004 | 24 | |
| 4 | 2020 | 5 | |
| 5 | 2006 | 3 | |
| 6 | 2017 | 3 | |
| 7 | 2018 | 2 | |
| 8 | 2006 | 1 | |
| 9 | 2024 | 1 | |
| 10 | 2024 | 1 | |
| 11 | 2012 | 1 |
About M.Á. Climent
M.Á. Climent is a scholar working on Surgery, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Neurology, having authored 11 papers that have together received 397 indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Sarcoma Diagnosis and Treatment (2 papers), Esophageal Cancer Research and Treatment (2 papers), Testicular diseases and treatments (2 papers), Urologic and reproductive health conditions (1 paper), Epilepsy research and treatment (1 paper) and Renal cell carcinoma treatment (1 paper). The work is most often cited by research in Oncology (184 citations), Surgery (252 citations), Pulmonary and Respiratory Medicine (65 citations), Cancer Research (17 citations) and Rheumatology (16 citations). M.Á. Climent has collaborated with scholars based in Spain, United States and Canada. Frequent co-authors include Dean F. Bajorin, Ronald de Wit, Andrea Necchi, Daniel P. Petrylak, Joaquim Bellmunt, Yves Fradet, K. Nam, Stéphane Culine, Howard Gurney and David J. Vaughn. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, World Neurosurgery, European Journal of Cancer and ESMO Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.